Health
Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures – News-Medical.Net
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin…
Finding a potential therapeutic target to battle the coronavirus disease 2019 (COVID-19) pandemic is crucial. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus has now spread to 191 countries worldwide and has infected over 59.17 million people.
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2…
-
General11 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News20 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General18 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News12 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial